# Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.

> **NCT03370874** · PHASE3 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 150 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** ALLO-ASC-DFU
- **PROCEDURE:** Vehicle sheet

## Key facts

- **NCT ID:** NCT03370874
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-27
- **Primary completion:** 2019-12-09
- **Final completion:** 2020-02-20
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370874, "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03370874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*